This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
The Zacks Analyst Blog Highlights Visa, Chubb, HCA Healthcare, Colgate-Palmolive and Veeva
by Zacks Equity Research
Visa, Chubb, HCA Healthcare, Colgate-Palmolive and Veeva are included in this Analyst Blog.
Top Stock Reports for Visa, Chubb & HCA Healthcare
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Chubb Limited (CB) and HCA Healthcare, Inc. (HCA).
Veeva Systems' (VEEV) New Release to Address Supply-Chain Issues
by Zacks Equity Research
Veeva Systems' (VEEV) new cloud application is likely to improve efficiency and accelerate time-to-market by connecting systems and automating data aggregation, reviews and traceability.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Veeva Systems Inc. (VEEV) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Veeva (VEEV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Veeva (VEEV) Rises on Robust Earnings: More Room to Grow?
by Zacks Equity Research
Veeva (VEEV) reports better-than-expected earnings and revenues for the second quarter. The raised earnings outlook for fiscal 2024 reflects optimism. Will the uptrend in shares continue?
3 Stocks to Watch After Impressive Earnings Beats
by Shaun Pruitt
Impressive Q2 earnings beats were reassuring that the strong performances of these stocks could continue and that they should be sound investments going forward.
Veeva Systems (VEEV) Beats on Q2 Earnings, Revises FY24 Outlook
by Zacks Equity Research
Veeva Systems' (VEEV) fiscal Q2 results reflect impressive performances by both segments.
Is VanEck Morningstar Wide Moat ETF (MOAT) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for MOAT
Veeva Systems (VEEV) to Support Civica Rx Quality Control
by Zacks Equity Research
Veeva Systems' (VEEV) Vault LIMS will streamline internal testing and manufacturing while promoting lead time adherence.
Veeva Systems (VEEV) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Veeva Systems (VEEV) closed at $187.27 in the latest trading session, marking a -0.42% move from the prior day.
Reasons to Add Veeva Systems (VEEV) Stock to Your Portfolio
by Zacks Equity Research
Veeva Systems' (VEEV) strong product portfolio raises optimism about the stock.
Paycor HCM, Inc. (PYCR) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Paycor HCM, Inc. (PYCR) delivered earnings and revenue surprises of 33.33% and 2.62%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Veeva Systems (VEEV) Stock Moves -0.68%: What You Should Know
by Zacks Equity Research
In the latest trading session, Veeva Systems (VEEV) closed at $191.22, marking a -0.68% move from the previous day.
Should VanEck Morningstar Wide Moat ETF (MOAT) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for MOAT
Veeva Systems (VEEV) Stock Moves -0.03%: What You Should Know
by Zacks Equity Research
Veeva Systems (VEEV) closed the most recent trading day at $193.94, moving -0.03% from the previous trading session.
I3 Verticals (IIIV) Matches Q3 Earnings Estimates
by Zacks Equity Research
i3 Verticals (IIIV) delivered earnings and revenue surprises of 0% and 0.28%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Veeva Systems (VEEV) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Veeva Systems (VEEV) closed the most recent trading day at $199.71, moving +0.42% from the previous trading session.
Veeva Systems (VEEV) Recently Broke Out Above the 20-Day Moving Average
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Veeva (VEEV) Falls Nearly 3% on Morgan Stanley Downgrade
by Zacks Equity Research
Veeva's (VEEV) shares lose nearly 3% after Morgan Stanley downgrades the stock to underweight, citing potential revenue loss from Salesforce's entry into the Life Sciences customer relationship management market.
Is VanEck Morningstar Wide Moat ETF (MOAT) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for MOAT
Should VanEck Morningstar Wide Moat ETF (MOAT) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for MOAT
Veeva Systems (VEEV) Beats on Q1 Earnings, Ups FY24 Outlook
by Zacks Equity Research
Veeva Systems' (VEEV) fiscal Q1 results reflect impressive performances by both segments.
Compared to Estimates, Veeva (VEEV) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Veeva (VEEV) give a sense of how the business performed in the quarter ended April 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Veeva Systems (VEEV) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Veeva (VEEV) delivered earnings and revenue surprises of 15.19% and 2.11%, respectively, for the quarter ended April 2023. Do the numbers hold clues to what lies ahead for the stock?